Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
5.23
+0.02 (0.38%)
At close: Jun 20, 2025, 4:00 PM
5.30
+0.07 (1.34%)
After-hours: Jun 20, 2025, 5:44 PM EDT
Vir Biotechnology Stock Forecast
Stock Price Forecast
The 7 analysts that cover Vir Biotechnology stock have a consensus rating of "Strong Buy" and an average price target of $32.86, which forecasts a 528.3% increase in the stock price over the next year. The lowest target is $14 and the highest is $110.
Price Target: $32.86 (+528.3%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 22, 2025.
Analyst Ratings
The average analyst rating for Vir Biotechnology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +167.69% | May 22, 2025 |
| Needham | Needham | Strong Buy Maintains $19 → $14 | Strong Buy | Maintains | $19 → $14 | +167.69% | May 12, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $28 → $21 | Strong Buy | Maintains | $28 → $21 | +301.53% | Apr 17, 2025 |
| Barclays | Barclays | Buy Maintains $26 → $31 | Buy | Maintains | $26 → $31 | +492.73% | Feb 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $110 | Strong Buy | Reiterates | $110 | +2,003.25% | Feb 28, 2025 |
Financial Forecast
Revenue This Year
16.54M
from 74.21M
Decreased by -77.71%
Revenue Next Year
16.41M
from 16.54M
Decreased by -0.77%
EPS This Year
-3.23
from -3.83
EPS Next Year
-3.12
from -3.23
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 71.4M | 55.2M | 49.5M | ||
| Avg | 16.5M | 16.4M | 24.1M | ||
| Low | 2.9M | 2.9M | 4.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -3.8% | 233.7% | 201.7% | ||
| Avg | -77.7% | -0.8% | 46.7% | ||
| Low | -96.0% | -82.2% | -70.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.60 | -2.34 | -1.68 | ||
| Avg | -3.23 | -3.12 | -2.82 | ||
| Low | -3.99 | -4.15 | -3.99 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.